Dr. Margarete Fischer-Bosch-Institute of Clinical Pharmacology
In research, Dr. Margarete Fischer-Bosch-Institute of Clinical Pharmacology stands highest in Medicine (#2,344 of 17,978 worldwide), Health Sciences (#3,180 of 20,462 worldwide) and Life Sciences (#3,020 of 14,347 worldwide), over all time.
- World rank, 2022–2025
- #14,247 of 28,054 · #6,208 all time
- Rank in Germany
- #549 of 1,178
- Research works
- 805 ▼ 25% vs 2013–17
- Citations
- 45k 56.0 per fractional work
- Top-10% rate
- 27.0% record average 16.5%
- Open access
- 29% world 28%
What is Dr. Margarete Fischer-Bosch-Institute of Clinical Pharmacology known for in research?
The fields where it stands highest, over all time, ranked among every institution above the floor in each field.
| Field | World rank | Where that sits | Top-10% rate | Works |
|---|---|---|---|---|
| MedicineField | #2,344 of 17,978 | 34.8% | 384 | |
| Health SciencesDomain | #3,180 of 20,462 | 34.7% | 396 | |
| Life SciencesDomain | #3,020 of 14,347 | 33.8% | 340 | |
| Biochemistry, Genetics and Molecular BiologyField | #2,827 of 7,814 | 25.6% | 181 |
Each strip is that field’s whole ranked pool, with the notch where Dr. Margarete Fischer-Bosch-Institute of Clinical Pharmacology sits in it, in the colour of the band that rank falls in. The track under the rate is the rate itself: it carries no world mark, because the world rate differs by field (from about 6% to 21% in this record).
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Pharmacology, Toxicology and Pharmaceutics, 20.4×. Every wedge is a field page.
- Pharmacology, Toxicology and Pharmaceutics 20.4×
- Biochemistry, Genetics and Molecular Biology 5.0×
- Immunology and Microbiology 2.9×
- Medicine 2.5×
- Veterinary 2.4×
- Chemistry 1.6×
- Nursing 1.5×
- Neuroscience 1.0×
- Health Professions 0.3×
- Engineering 0.2×
- Mathematics 0.2×
- Computer Science 0.2×
- Materials Science 0.2×
- Environmental Science 0.2×
- Agricultural and Biological Sciences 0.1×
- Economics, Econometrics and Finance 0.1×
- Psychology 0.1×
- Business, Management and Accounting 0.0×
- Social Sciences 0.0×
- Decision Sciences 0.0×
Who are the top researchers at Dr. Margarete Fischer-Bosch-Institute of Clinical Pharmacology?
Ranked on the composite score, Michel Eichelbaum, Matthias Schwab and Ulrich M. Zanger lead among researchers whose main affiliation is Dr. Margarete Fischer-Bosch-Institute of Clinical Pharmacology.
- 1 Michel Eichelbaum Germany · #26,477 worldwide 444 citations · 51 works
- 2 Matthias Schwab Germany · #38,048 worldwide 1.1k citations · 155 works
- 3 Ulrich M. Zanger Germany · #49,103 worldwide 744 citations · 29 works
- 4 Hiltrud Brauch Germany · #55,626 worldwide 675 citations · 94 works
- 5 Ulrich Klotz Germany · #129,747 worldwide 290 citations · 82 works
- 6 Jan Wehkamp Germany · #140,209 worldwide 262 citations · 45 works
- 7 Stefan Winter Germany · #282,841 worldwide 112 citations · 23 works
- 8 Reiner Hoppe Germany · #441,536 worldwide 70 citations · 21 works
- 9 Elke Schaeffeler Germany · #560,429 worldwide 79 citations · 32 works
- 10 Ute Hofmann Germany · #1,081,310 worldwide 40 citations · 29 works
Which keywords describe research at Dr. Margarete Fischer-Bosch-Institute of Clinical Pharmacology?
By fractional works in 2022–2025, weighted toward what it does more of than the world: Pharmacokinetics, Genetic Variation, Cytochrome P450, Drug Metabolism, Enzyme Activities, Pharmacogenetics, Inflammation and Oxidative Stress.
- Therapeutic Targets
- ATP-dependent Transporters
- Stem Cell Niches
- Hepatocellular Carcinoma
- Cancer Stem Cells
- Molecular Profiling
- Metabolism
- Bioprinting
- Classification
- Insulin Resistance
- Nuclear Receptors
- Cancer Therapy
- PET Imaging
- Cell Culture
- Rituximab
- Metabolic Syndrome
- Pharmacogenetics
- Drug Metabolism
- Genetic Variation
- Inflammation
- Pharmacokinetics
- Cytochrome P450
- Oxidative Stress
- Enzyme Activities
- Cancer
- Prognostic Factors
- Regenerative Medicine
- Metabolic Regulation
- Tumor Microenvironment
- Lymphoma
- Chemotherapy
- Tissue Engineering
- Drug Resistance
- Epithelial-Mesenchymal Transition
- Microfluidic Devices
- Tumor Metastasis
- Genetic Pathogenesis
- Hodgkin's Lymphoma
- Angiogenesis
- Multidrug Resistance
Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 40 words, with their numbers
- Pharmacokinetics5▲ 29×4 topics
- Inflammation5▲ 3.6×29 topics
- Cytochrome P4504▲ 205×2 topics
- Genetic Variation4▲ 32×5 topics
- Oxidative Stress4▲ 4.1×22 topics
- Drug Metabolism4▲ 236×2 topics
- Enzyme Activities4▲ 308×1 topic
- Pharmacogenetics4▲ 308×1 topic
- Cancer3▲ 3.8×29 topics
- Metabolic Syndrome3▲ 5.1×11 topics
- Prognostic Factors3▲ 9.7×9 topics
- Rituximab3▲ 27×2 topics
- Regenerative Medicine2▲ 16×3 topics
- Cell Culture2▲ 32×2 topics
- Metabolic Regulation2▲ 21×4 topics
- PET Imaging2▲ 21×4 topics
- Tumor Microenvironment2▲ 8.0×6 topics
- Cancer Therapy2▲ 5.9×13 topics
- Lymphoma2▲ 21×3 topics
- Nuclear Receptors2▲ 39×3 topics
- Chemotherapy2▲ 4.5×13 topics
- Insulin Resistance2▲ 6.7×5 topics
- Tissue Engineering2▲ 5.0×4 topics
- Classification2▲ 6.6×3 topics
- Drug Resistance2▲ 10×3 topics
- Bioprinting2▲ 46×1 topic
- Epithelial-Mesenchymal Transition2▲ 29×2 topics
- Metabolism2▲ 5.4×9 topics
- Microfluidic Devices2▲ 23×1 topic
- Molecular Profiling2▲ 28×2 topics
- Tumor Metastasis2▲ 49×2 topics
- Cancer Stem Cells2▲ 61×1 topic
- Genetic Pathogenesis2▲ 50×1 topic
- Hepatocellular Carcinoma2▲ 13×3 topics
- Hodgkin's Lymphoma2▲ 50×1 topic
- Stem Cell Niches2▲ 61×1 topic
- Angiogenesis2▲ 7.7×10 topics
- ATP-dependent Transporters2▲ 94×1 topic
- Multidrug Resistance2▲ 71×1 topic
- Therapeutic Targets2▲ 16×7 topics
Which research topics does Dr. Margarete Fischer-Bosch-Institute of Clinical Pharmacology publish most on?
By volume in 2022–2025: Pharmacogenetics and Drug Metabolism, 3D Printing in Biomedical Research, Lymphoma Diagnosis and Treatment and Cancer Cells and Metastasis.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Pharmacogenetics and Drug Metabolism Pharmacology 4 works
- 2 3D Printing in Biomedical Research Biomedical Engineering 2 works
- 3 Lymphoma Diagnosis and Treatment Pathology and Forensic Medicine 2 works
- 4 Cancer Cells and Metastasis Oncology 2 works
- 5 Drug Transport and Resistance Mechanisms Oncology 2 works
- 6 Liver Disease Diagnosis and Treatment Epidemiology 1 works
- 7 Cancer Genomics and Diagnostics Cancer Research 1 works
- 8 Genomics and Rare Diseases Genetics 1 works
- 9 Cancer, Hypoxia, and Metabolism Cancer Research 1 works
- 10 Chronic Lymphocytic Leukemia Research Genetics 1 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has Dr. Margarete Fischer-Bosch-Institute of Clinical Pharmacology's research output changed?
Output in 2018–2022 was 25% lower than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Stuttgart
- University of Stuttgart
- University of Hohenheim
- Max Planck Institute for Solid State Research
- Stuttgart Observatory
- Alcatel Lucent (Germany)
- Daimler (Germany)
- Robert Bosch (Germany)
- Stuttgart Technical University of Applied Sciences
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.